Cadila Healthcare gets USFDA nod Fluphenazine Hydrochloride Tablets

Read more about Cadila Healthcare gets USFDA nod Fluphenazine Hydrochloride Tablets on Business Standard. Cadila Healthcare has received final approval from the USFDA to market Fluphenazine Hydrochloride Tablets in the strengths of 1 mg, 2.5 mg, 5 mg, and 10 mg.

Related Keywords

Ahmedabad ,Gujarat ,India , ,Cadila Healthcare ,Fluphenazine Hydrochloride Tablets ,Capital Market ,Drugs ,Combination Drugs ,Cadila Pharmaceuticals ,Companies Based In Ahmedabad ,Mg Cars ,Potassium Channel Blockers ,Pseudoephedrine ,Initran ,Generic Pharmaceuticals ,Harmaceutical ,Formulation Manufacturing Facility ,Schizophrenia ,Luphenazine ,Healthcare ,அஹமதாபாத் ,குஜராத் ,இந்தியா ,காடிலா சுகாதாரம் ,மூலதனம் சந்தை ,மருந்துகள் ,